Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Universe Pharmaceuticals INC (UPC)

NCM · Drug Manufacturers - Specialty & Generic

$3.19-0.26 (-7.54%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$2.1M
P/E (TTM)
EPS
$-7.38
Div Yield
52W Range
$2.00–$17.96
Beta
1.46

Company overview

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

Universe Pharmaceuticals INC has not issued a press release in this window.

SEC filings

All filings →

Universe Pharmaceuticals INC has not filed an SEC document in this window.

Universe Pharmaceuticals INC has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
946 sh+94500.0%

People at Universe Pharmaceuticals INC

All people →

Quarterly financials

Full financials →
Revenue trend
09/24
$23.0M
NI -$8.7M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.